Advertisement
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
This site complies with the HONcode standard for trustworthy health information: verify here .
Susan Hasty, Publisher Table of Contents . . . July 6th, 2009 Non-Subscriber - Summaries Only Related Areas: Other Issues in Cancer Vaccine Week | Other Publications
Cancer Vaccines - Data from Vrije University Amsterdam provide new insights into cancer vaccinesCancer Vaccines - Investigators at University of Louisville release new data on cancer vaccinesCancer Vaccines - New findings reported from J. Rossowska and co-authors describe advances in cancer vaccinesCancer Vaccines - Research from V. Francois and colleagues has provided new data on cancer vaccinesCancer Vaccines - Researchers at University of Bonn have published new data on cancer vaccinesCancer Vaccines - Studies from F.C. Stark and colleagues reveal new findings on cancer vaccinesGene Therapy - Researchers at Merck & Company, Inc. target gene therapyImmunoCellular Therapeutics, Ltd. - ImmunoCellular Therapeutics Signs Manufacturing Agreement with Formatech for Clinical Trial of ICT-121 ImmunotherapyMelanoma - Research results from Vrije University, Medical Department update understanding of melanomaRetrovirus - Researchers from Food & Drug Administration detail new studies and findings in the area of retrovirus
Hepatitis C Virus Therapy - New findings from University of Amsterdam in the area of hepatitis C virus therapy publishedImmunization - Researchers from University of Melbourne, Center for Animal Biotechnology detail findings in immunizationADA Technologies, Inc. - ADA Technologies Receives $1.15 Million NIH GrantAdvaxis, Inc. - Advaxis Completes Debt FinancingAdvaxis, Incorporated - Advaxis Engages the Numoda Corporation to Oversee Phase II Clinical Trials of ADXS11-001Antigenics Inc. - Antigenics Announces Expansion of Investigator-Sponsored Study for GliomaCancer Vaccines - CEL-SCI Signs Definitive Agreement to Raise $5 Million in Registered Direct OfferingCancer Vaccines - Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancerCEL-SCI Corporation - CEL-SCI Posts New Corporate Presentation to WebsiteHeart Attack - New Survey Finds Majority of Adults Dont Understand a Key Source of High Blood PressureLaboratory Corporation of America® Holdings - LabCorp Enters Definitive Agreement to Acquire Monogram Biosciences, Inc.Merck KGaA - Merck KGaA Initiates Phase III Study of Stimuvax in Breast Cancer
Return to Top of Page
